Serentis' Series A - II Round

Serentis raised a round of funding on August 12, 2008.

Serentis is a biopharmaceutical company which aims to develop a pipeline of products to address unmet medical needs in the dermatology field. The company's strategy is to establish a clinical stage de…

Articles about Serentis' Series A - II Round: